Brandon Mahal, M.D. Physician Scientist University of Miami Miller School of Medicine Sylvester Comprehensive Cancer Center Dr. Brandon Mahal is a physician-scientist at the University of Miami Miller School of Medicine (MSOM)-Sylvester Comprehensive Cancer Center (SCCC), where he treats prostate and genitourinary cancers. He obtained his Doctor of Medicine (M.D.) with Honors at Harvard Medical School, completed an internal medicine internship at Harvard Medical School’s Brigham and Women’s Hospital, and completed residency in radiation oncology at the Harvard Radiation Oncology Program.Dr. Mahal is an internationally recognized expert in prostate cancer and health equity, with over 200 co-authored manuscripts including several publications in top medical journals such as NEJM, JAMA, and JAMA Oncology. He has served on several expert committees and panels, including The White House’s Health Equity Leader Roundtable, The Lancet Commission on Prostate Cancer, The American Society for Clinical Oncology (ASCO) Guideline Panel on Genomics for Prostate Cancer, ASCO-Friends Cancer Research Group, American Cancer Society (ACS) National Advisory Team on Prostate Cancer Disparities, and Prostate Cancer Foundation Disparities Working Group.Dr. Mahal also leads a research lab that focuses on prostate cancer, translational epidemiology, genomics, and scientific outreach/engagement in the context of addressing cancer disparities. His work is funded by the Prostate Cancer Foundation (PCF), American Society for Radiation Oncology (ASTRO), Department of Defense (DOD), National Institutes of Health (NIH), and generous donations through the Sylvester Comprehensive Cancer Center (SCCC).
Dr. Brandon Mahal is a physician-scientist at the University of Miami Miller School of Medicine (MSOM)-Sylvester Comprehensive Cancer Center (SCCC), where he treats prostate and genitourinary cancers. He obtained his Doctor of Medicine (M.D.) with Honors at Harvard Medical School, completed an internal medicine internship at Harvard Medical School’s Brigham and Women’s Hospital, and completed residency in radiation oncology at the Harvard Radiation Oncology Program.Dr. Mahal is an internationally recognized expert in prostate cancer and health equity, with over 200 co-authored manuscripts including several publications in top medical journals such as NEJM, JAMA, and JAMA Oncology. He has served on several expert committees and panels, including The White House’s Health Equity Leader Roundtable, The Lancet Commission on Prostate Cancer, The American Society for Clinical Oncology (ASCO) Guideline Panel on Genomics for Prostate Cancer, ASCO-Friends Cancer Research Group, American Cancer Society (ACS) National Advisory Team on Prostate Cancer Disparities, and Prostate Cancer Foundation Disparities Working Group.Dr. Mahal also leads a research lab that focuses on prostate cancer, translational epidemiology, genomics, and scientific outreach/engagement in the context of addressing cancer disparities. His work is funded by the Prostate Cancer Foundation (PCF), American Society for Radiation Oncology (ASTRO), Department of Defense (DOD), National Institutes of Health (NIH), and generous donations through the Sylvester Comprehensive Cancer Center (SCCC).
